Literature DB >> 24223244

Evaluation of the sensitivity and specificity of immunohistochemical markers in the differential diagnosis of effusion cytology.

Zahraa Mohammed Yahya1, Hussam Hasson Ali, Haider Ghazi Hussein.   

Abstract

OBJECTIVE: To evaluate the sensitivity and specificity of Calretinin and Carcinoembryonic antigen as immunocytochemical markers in distinguishing mesothelial cells from metastatic adenocarcinoma cells in effusion cytology.
METHODS: This study included 50 patients who presented with effusions (26 pleural and 24 peritoneal), at Al-Kadhimya Teaching Hospital who were selected according to their preliminary diagnosis from 1st December 2010 to 30th June 2011. Effusion fluids were aspirated and processed for both conventional cytological methods using Papanicolaou-stain and immunocytochemical staining with anti Calretinin and Carcinoembryonic antigen.
RESULTS: The sensitivity of cytology for detection of malignant cells was 77%, with 100% specificity and 86% accuracy. Calretinin was observed to be a specific (100%) and sensitive (90%) marker for mesothelial cells (of benign etiology). Carcinoembryonic antigen exhibited 70% sensitivity and 100% specificity for adenocarcinoma cells. When the results of both cytology and immunocytochemistry were considered in conjunction, the sensitivity for the detection of malignancy increased to 97%, with 100% specificity and 98% accuracy.
CONCLUSION: Calretinin and Carcinoembryonic antigen were found to be useful markers for differentiating reactive mesothelial cells from metastatic adenocarcinoma cells in smears prepared from body fluids. Also, the combination of both cytology and immunocytochemical studies using the two markers can greatly enhance the diagnostic accuracy, sensitivity and specificity in malignant effusions.

Entities:  

Keywords:  Adenocarcinoma; Calretinin; Carcinoembryonic antigen; Effusion; Mesothelial Cells

Year:  2013        PMID: 24223244      PMCID: PMC3815850          DOI: 10.5001/omj.2013.117

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  22 in total

1.  Clinical practice. Pleural effusion.

Authors:  Richard W Light
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

2.  Improved identification of malignant cells in serous effusions using a small, robust panel of antibodies on paraffin-embedded cell suspensions.

Authors:  Johanna M M Grefte; Peter C de Wilde; Maria R J Salet-van de Pol; Marc Tomassen; Wilhelmina L Raaymakers-van Geloof; Johan Bulten
Journal:  Acta Cytol       Date:  2008 Jan-Feb       Impact factor: 2.319

3.  Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology.

Authors:  E C Ko; N C Jhala; J J Shultz; D C Chhieng
Journal:  Am J Clin Pathol       Date:  2001-11       Impact factor: 2.493

4.  Immunohistochemical expression of estrogen and progesterone receptors in human colorectal adenoma and carcinoma using specified automated cellular image analysis system: a clinicopathological study.

Authors:  Ban Jumaa Qasim; Hussam Hasson Ali; Alaa Ghani Hussein
Journal:  Oman Med J       Date:  2011-09

5.  Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium.

Authors:  Ayuko Sato; Ikuko Torii; Yoshihiro Okamura; Tadashi Yamamoto; Takashi Nishigami; Tatsuki R Kataoka; Misa Song; Seiki Hasegawa; Takashi Nakano; Toshiaki Kamei; Tohru Tsujimura
Journal:  Mod Pathol       Date:  2010-07-23       Impact factor: 7.842

Review 6.  The diagnosis of malignancy in effusion cytology: a pattern recognition approach.

Authors:  Telma C Pereira; Reda S Saad; Yulin Liu; Jan F Silverman
Journal:  Adv Anat Pathol       Date:  2006-07       Impact factor: 3.875

7.  Immunohistochemical Expression of Ki-67, PCNA and CD34 in Astrocytomas: A Clinicopathological Study.

Authors:  Mohammed Kassim Chaloob; Hussam Hasson Ali; Ban Jumaa Qasim; Ahmed Salahaldeen Mohammed
Journal:  Oman Med J       Date:  2012-09

8.  Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.

Authors:  Krisztina Z Hanley; Michael S Facik; Patricia A Bourne; Qi Yang; Betsy O Spaulding; Thomas A Bonfiglio; Haodong Xu
Journal:  Cancer       Date:  2008-02-25       Impact factor: 6.860

9.  Utility of fibronectin in immuocytochemial differentiation of reactive mesothelial cells from metastatic malignant cells in serous effusions.

Authors:  Chetna Agarwal; Manjula Jain
Journal:  Indian J Pathol Microbiol       Date:  2009 Jan-Mar       Impact factor: 0.740

Review 10.  Immunohistochemical distinction between mesothelial and adenocarcinoma cells in serous effusions: a combination panel-based approach with a brief review of the literature.

Authors:  Paari Murugan; Neelaiah Siddaraju; Syed Habeebullah; Debdatta Basu
Journal:  Indian J Pathol Microbiol       Date:  2009 Apr-Jun       Impact factor: 0.740

View more
  3 in total

1.  Utility of immunochemistry in cytology.

Authors:  Pooja Chavali; Aruna Kumari Prayaga; Ashwani Tandon; Shantveer Gurulingappa Uppin
Journal:  J Cytol       Date:  2016 Apr-Jun       Impact factor: 1.000

2.  Diagnostic Utility of Epithelial Membrane Antigen (EMA) and Calretinin (CAL) in Effusion Cytology.

Authors:  Neha Nautiyal; Aparna Bhardwaj; Seema Acharya; Sanjeev Kishore; Sandip Kudesia
Journal:  J Clin Diagn Res       Date:  2017-05-01

3.  Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion.

Authors:  Yan Gu; Kan Zhai; Huan-Zhong Shi
Journal:  Chin Med J (Engl)       Date:  2016-02-05       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.